Abstract
Purpose
Tranexamic acid has been shown to be effective in reducing blood loss after total hip replacement. The purpose of this study was to prospectively assess the effectiveness of topical TXA use to reduce blood loss after primary total hip replacement and to compare these outcomes with those of a matched control group from a similar cohort that did not have received tranexamic acid.
Methods
This is a prospective matched control study to assess the effect of a 2 g topical tranexamic acid in 50 mL physiological saline solution in total hip replacement. Primary outcomes were hemoglobin and hematocrit drop, and total blood loss. Secondary outcomes were transfusion rates, length of hospital stay, deep vein thrombosis, and pulmonary embolism events.
Results
We could match 100 patients to a control group. There were no statistical significantly differences between the two groups. The hemoglobin and hematocrit postoperative values were significantly higher in topical tranexamic acid group than in control group (P < 0.001). The mean total blood loss was 769 in topical tranexamic acid group and 1163 in control group with significant differences (P = 0.001), which meant 34% reduction in total blood loss. Length of stay was lower in topical tranexamic acid group. The risk of deep vein thrombosis and pulmonary events did not increase.
Conclusions
A single dose of 2 g tranexamic acid in 50 mL physiological saline solution topical administration was effective and safe in reducing bleeding in patients undergoing unilateral primary non-cemented total hip replacement compared to a matched control group.
Similar content being viewed by others
References
Gibon E, Courpied JP, Hamadouche M (2013) Total joint replacement and blood loss: what is the best equation? Int Orthop 37:735–739
Watts CD, Pagnano MW (2012) Minimising blood loss and transfusion in contemporary hip and knee arthroplasty. J Bone Joint Surg Br 94:8–10
Sukeik M, Alshryda S, Haddad FS, Mason JM (2011) Systematic review and metaanalysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 93:39–46
Zhou XD, Tao LJ, Li J, Wu LD (2013) Do we really need tranexamic acid in total hip arthroplasty? a meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg 133:1017–1027
Melvin JS, Stryker LS, Sierra RJ (2015) Tranexamic acid in hip and knee arthroplasty. J Am Acad Orthop Surg 23:732
Chen S, Wu K, Kong G, Feng W, Deng Z, Wang H (2016) The efficacy of topical tranexamic acid in total hip arthroplasty: a meta-analysis. BMC Musculoskelet Disord 17:81
Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM (2014) A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J 96:1005–1015
Wang C, Xu G, Han Z, Ma J, Ma X, Jiang X, Wang Y (2015) Topical application of tranexamic acid in primary total hip arthroplasty: a systemic review and meta-analysis. Int J Surg 15:134–139
Good L, Peterson E, Lisander B (2003) Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 90:596
Nadler SB, Hidalgo JU, Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51:224
Konig G, Hamlin BR, Waters JH (2013) Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplast 28:1473–1476
Gilbody J, Dhotar HS, Perruccio AV et al (2014) Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplast 29:681–684
Wind TC, Barfield WR, Moskal JT (2014) The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplast 29:387–389
Wei W, Wei B (2014) Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty. J Arthroplast 29:2113–2136
North WT, Mehran N, Davis JJ et al (2016) Topical vs intravenous tranexamic acid in primary total hip arthroplasty: a double-blind, randomized controlled trial. J Arthroplast 31:1022–1026
Ueno M, Sonohata M, Fukumori N, Kawano S, Kitajima M, Mawatari M (2016) Comparison between topical and intravenous administration of tranexamic acid in primary total hip arthroplasty. J Orthopc Sci 21:44–47
Martin JG, Cassatt KB, Kincaid-Cinnamon KA et al (2014) Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplast 29:889–894
Yue C, Kang P, Yang P et al (2014) Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplast 29:2452–2456
Kasparek MF, Faschingbauer M, Waldstein W et al (2017) Topical tranexamic acid is equivalent to targeted preoperative autologous blood donation in total hip arthroplasty. J Arthroplast 32:1176–1179
Yi Z, Bin S, Jing Y, Zongke Z, Pengde K, Fuxing P (2016) Tranexamic acid administration in primary total hip arthroplasty. a randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. J Bone Joint Surg Am 98:983–991
Mannucci PM (1998) Hemostatic drugs. N Engl J Med 339:245–253
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
IRB approval and informed consent were obtained.
Rights and permissions
About this article
Cite this article
Sanz-Reig, J., Mas Martinez, J., Verdu Román, C. et al. Matched cohort study of topical tranexamic acid in cementless primary total hip replacement. Eur J Orthop Surg Traumatol 28, 1335–1339 (2018). https://doi.org/10.1007/s00590-018-2192-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-018-2192-0